Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

HVH-2930

HVH-2930 is a potent HSP90 inhibitor that reduces viability in both trastuzumab-sensitive and -resistant breast cancer cell lines by degrading key client proteins like HER2 and AKT. It demonstrates significant in vivo antitumor activity and favorable pharmacokinetics, supporting its use in oncology research for studying HSP90-dependent pathways and therapeutic resistance.

Product Specifications

CAS Number

3034605-72-3

Field of Research

Cardiovascular Research, Cell Biology, Metabolism Research, Signal Transduction

Smiles

O=C (NC=1C=CC=2C (=NN (C2C1) CCC3CCN (C) CC3) C) C4=CC=C5OC (C=CC5=C4OC) (C) C

Molecular Formula

C29H36N4O3

Molecular Weight

488.62

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human early prostate cancer antigen 2, EPCA2 ELISA Kit
MBS706667-01 24 Well (LIMIT 1)

Human early prostate cancer antigen 2, EPCA2 ELISA Kit

Sign In for Pricing
View Details
Human early prostate cancer antigen 2, EPCA2 ELISA Kit
MBS706667-02 48 Well

Human early prostate cancer antigen 2, EPCA2 ELISA Kit

Sign In for Pricing
View Details
Human early prostate cancer antigen 2, EPCA2 ELISA Kit
MBS706667-03 96 Well

Human early prostate cancer antigen 2, EPCA2 ELISA Kit

Sign In for Pricing
View Details
Human early prostate cancer antigen 2, EPCA2 ELISA Kit
MBS706667-04 5x 96 Well

Human early prostate cancer antigen 2, EPCA2 ELISA Kit

Sign In for Pricing
View Details
Human early prostate cancer antigen 2, EPCA2 ELISA Kit
MBS706667-05 10x 96 Well

Human early prostate cancer antigen 2, EPCA2 ELISA Kit

Sign In for Pricing
View Details
HDAC6 discontinued
537148-01 30ul

HDAC6 discontinued

Sign In for Pricing
View Details